MUC1 and neoplasm: Other aspects revealed a significant decrease in tumor markers of carcinoembryonic antigen (CEA), cancer antigen 15.3 (CA15.3), and cancer antigen 125 (CA125) with Amygdalin administrations, whether in treatment or protection group inconsistent with Jaswal et al.57.